Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.5502
+0.0102 (1.89%)
Aug 18, 2026, 12:22 PM EDT - Market open
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $8.38 million as of August 18, 2026. Its market cap has decreased by -21.45% in one year.
Market Cap
8.38M
Enterprise Value
3.36M
1-Year Change
-21.45%
Ranking
Category
Stock Price
$0.55
ChartMarket Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $8.38M, a decrease of -97.95%. That is a compound annual growth rate of -25.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 8.38M | -7.21% |
| Dec 31, 2025 | 9.03M | -72.02% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuron | 8.99M |
| Imunon | 8.98M |
| BioVie | 8.82M |
| Exicure | 8.80M |
| Aprea Therapeutics | 8.69M |
| Soligenix | 8.30M |
| CNS Pharmaceuticals | 7.89M |
| Xenetic Biosciences | 7.64M |